Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial
Title:
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial
Author:
Ruel, Theodore D Acosta, Edward P Liu, Jessica P Gray, Kathryn P George, Kathleen Montañez, Nicole Popson, Stephanie Buchanan, Ann M Bartlett, Mattie Dayton, Dale Anthony, Patricia Brothers, Cynthia Vavro, Cynthia Singh, Rajendra Koech, Lucy Vhembo, Tichaona Mmbaga, Blandina T Pinto, Jorge A Dobbels, Els F M Archary, Moherndran Chokephaibulkit, Kulkanya Ounchanum, Pradthana Deville, Jaime G Hazra, Rohan Townley, Ellen Wiznia, Andrew
Appeared in:
The Lancet. HIV
Paging:
Volume 9 () nr. 5 pages e332-e340
Year:
2022
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license